Schrodinger: More Than An AI Bubble Stock (NASDAQ:SDGR)

Jonathan Kitchen Schrodinger’s (NASDAQ:SDGR) stock has surged this year on the back of AI hype and continued strength in its drug discovery business. Schrodinger is far more than an AI bubble stock though. As the drug discovery business matures, the importance of Schrodinger’s platform is becoming more apparent, and AI only enhances this. While the…

Read More

Schrodinger: A Computational Platform That Is Likely Becoming Obsolete (SDGR)

~UserGI15994093/iStock via Getty Images Introduction Schrodinger (NASDAQ:SDGR) is a computational biology platform that uses a physics-informed algorithm, free energy perturbation (FEP), combined with machine learning to design drugs. In addition to licensing its code out to pharmaceutical companies, the company operates a partnership model, where SDGR will leverage its software and take equity or cash…

Read More